A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects

Inclusion Criteria: * Subjects with a history of systemic diabetes(type I,or II) * Subject with a documented history of Non- proliferative Diabetic Retinopathy(NPDR) * Subjects with no or partial PVD at baseline exam in study eye. Exclusion Criteria: * Subjects with retinal pathology in the study eye other then (NPDR) * Subjects with high myopia in the study eye * Subjects who have monocular vision or central lateral vision of 20/200 or worse BCVA in the non-study eye. * Subjects with an aphakic study eye or if pseudophakic, cataract extraction surgery less then 6 months prior to study enrollment. * Subjects that have either vitrectomy surgery, intavitreal injections, or laser treatments in the study eye.